Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children

Inclusion Criteria:

- healthy 2-10 years of age children, inclusive and for whom, after the nature of the
study has been explained, the parent or legal guardian has provided written informed
consent

- who are available for all visits and telephone calls scheduled for the study

- who are up-to-date with age-appropriate routine childhood vaccinations

Exclusion Criteria:

- whose parent or legal guardian is unwilling or unable to give written informed
consent

- who had a previous or suspected disease caused by N. meningitidis;

- who have previously been immunized with a meningococcal vaccine or vaccine containing
meningococcal antigen(s)

- who have received any investigational agents or vaccines within 90 days prior to
enrollment

- who have any serious acute, chronic or progressive disease

- who have epilepsy or any progressive neurological disease or history of Guillain
Barré Syndrome

- who have a history of anaphylaxis, serious vaccine reactions

- who have a known or suspected impairment/alteration of immune function, either
congenital or acquired or resulting from

- who are known to have a bleeding diathesis, or any condition that may be associated
with a prolonged bleeding time

- who have Down's syndrome or other known cytogenic disorders